Automation of Radiation Treatment Planning for Rectal Cancer

TL;DR

This paper presents an automated workflow combining deep learning and optimization algorithms to generate clinically acceptable radiotherapy plans for rectal cancer, significantly reducing manual effort and improving plan quality.

Contribution

The authors developed and validated an end-to-end automated system for rectal cancer radiotherapy planning, integrating DL aperture prediction with a novel planning algorithm, achieving high clinical acceptability.

Findings

DL models achieved high Dice scores (>0.90) for aperture prediction.

97% of plans generated by the system were clinically acceptable.

Hotspot dose was reduced from 121% to 109% of the prescription dose.

Abstract

To develop an automated workflow for rectal cancer three-dimensional conformal radiotherapy treatment planning that combines deep-learning(DL) aperture predictions and forward-planning algorithms. We designed an algorithm to automate the clinical workflow for planning with field-in-field. DL models were trained, validated, and tested on 555 patients to automatically generate aperture shapes for primary and boost fields. Network inputs were digitally reconstructed radiography, gross tumor volume(GTV), and nodal GTV. A physician scored each aperture for 20 patients on a 5-point scale(>3 acceptable). A planning algorithm was then developed to create a homogeneous dose using a combination of wedges and subfields. The algorithm iteratively identifies a hotspot volume, creates a subfield, and optimizes beam weight all without user intervention. The algorithm was tested on 20 patients using clinical apertures with different settings, and the resulting plans(4 plans/patient) were scored by a physician. The end-to-end workflow was tested and scored by a physician on 39 patients using DL-generated apertures and planning algorithms. The predicted apertures had Dice scores of 0.95, 0.94, and 0.90 for posterior-anterior, laterals, and boost fields, respectively. 100%, 95%, and 87.5% of the posterior-anterior, laterals, and boost apertures were scored as clinically acceptable, respectively. Wedged and non-wedged plans were clinically acceptable for 85% and 50% of patients, respectively. The final plans hotspot dose percentage was reduced from 121%($\pm$ 14%) to 109%($\pm$ 5%) of prescription dose. The integrated end-to-end workflow of automatically generated apertures and optimized field-in-field planning gave clinically acceptable plans for 38/39(97%) of patients. We have successfully automated the clinical workflow for generating radiotherapy plans for rectal cancer for our institution.